{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:26:31Z","timestamp":1785461191372,"version":"3.56.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","award":["503\/3-021-01\/503-31-001"],"award-info":[{"award-number":["503\/3-021-01\/503-31-001"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013840","name":"Biocenter Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030846","name":"Biokeskus Kuopio, It\u00e4-Suomen yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019241","name":"CSC \u2013 IT Center for Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177886","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:36:03Z","timestamp":1751420163000},"page":"177886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Optimizing the structure of repurposed metformin can improve anti-cholinesterase and anti-amyloidogenic effects"],"prefix":"10.1016","volume":"1003","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1012-6550","authenticated-orcid":false,"given":"Magdalena","family":"Markowicz-Piasecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomo","family":"Laitinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1175-8517","authenticated-orcid":false,"given":"Kristiina M.","family":"Huttunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177886_bib1","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1021\/acs.jpcb.0c03778","article-title":"Physical mechanisms governing substituent E ff ects on arene \u2212 arene interactions in a protein milieu","volume":"124","author":"Andersson","year":"2020","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejphar.2025.177886_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2024.1330797","article-title":"Examining the clinical relevance of metformin as an antioxidant intervention","volume":"15","author":"Buczy\u0144ska","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177886_bib3","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1038\/sj.emboj.7601175","article-title":"Structural insights into substrate traffic and inhibition in acetylcholinesterase","volume":"25","author":"Colletier","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2025.177886_bib4","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s00702-006-0526-2","article-title":"Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment","volume":"113","author":"Darreh-Shori","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2025.177886_bib5","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.3390\/ijms13033038","article-title":"Unraveling the early events of amyloid-\u00df protein (a\u00df) aggregation: techniques for the determination of A\u03b2 aggregate size","volume":"13","author":"Elizabeth","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177886_bib6","doi-asserted-by":"crossref","first-page":"33944","DOI":"10.1039\/C7RA04180B","article-title":"A new guanylhydrazone derivative as a potential acetylcholinesterase inhibitor for alzheime \u2019S disease: synthesis, molecular docking , biological resonance","volume":"7","author":"Fereira Neto","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejphar.2025.177886_bib7","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","article-title":"Metformin : update on mechanisms of action and repurposing potential","volume":"19","author":"Foretz","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejphar.2025.177886_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.expneurol.2018.12.007","article-title":"Broadening the definition of brain insulin resistance in aging and Alzheimer's disease","volume":"313","author":"Frazier","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2025.177886_bib9","article-title":"A new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies","volume":"309","author":"Gerlit","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2025.177886_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1257700","article-title":"Drug repurposing for alzheimer \u2019 s disease from 2012 \u2013 2022 \u2014 a 10-year literature review","volume":"14","author":"Grabowska","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177886_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/DDDT.S432170","article-title":"In vitro and in vivo biological evaluation of newly tacrine-selegiline hybrids as multi-target inhibitors of cholinesterases and monoamine oxidases for alzheimer's disease","volume":"18","author":"Huang","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2025.177886_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106637","article-title":"Altering distribution profile of palbociclib by its prodrugs","volume":"192","author":"Jarvinen","year":"2024","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2025.177886_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22042033","article-title":"The role of butyrylcholinesterase and iron in the regulation of cholinergic network and cognitive dysfunction in alzheimer's disease pathogenesis","volume":"22","author":"Jasiecki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177886_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40262-015-0323-x","article-title":"Therapeutic concentrations of metformin: a systematic review","volume":"55","author":"Kajbaf","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2025.177886_bib15","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","article-title":"Is Alzheimer's disease a type 3 diabetes? A critical appraisal","volume":"1863","author":"Kandimalla","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2025.177886_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00004714-199912000-00005","article-title":"Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humans","volume":"19","author":"Kennedy","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2025.177886_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0969-2126(99)80040-9","article-title":"Structure of acetylcholinesterase complexed with E2020 (aricept \u00ae): implications for the design of new anti-alzheimer drugs","volume":"7","author":"Kryger","year":"1999","journal-title":"Structure"},{"key":"10.1016\/j.ejphar.2025.177886_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pnpbp.2017.06.002","article-title":"Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus","volume":"79","author":"Kuan","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.177886_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/toxsci\/kfv160","article-title":"Development of 3D-QSAR model for acetylcholinesterase inhibitors using a combination of fingerprint , molecular docking , and structure-based pharmacophore approaches","volume":"148","author":"Lee","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2025.177886_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7303096","article-title":"Metformin and its sulfenamide prodrugs inhibit human cholinesterase activity","volume":"2017","author":"Markowicz-Piasecka","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2025.177886_bib21","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1080\/14756366.2018.1499627","article-title":"Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation","volume":"33","author":"Markowicz-Piasecka","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.177886_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ph13100323","article-title":"Novel sulfonamide-based analogs of metformin exert promising anti-coagulant effects without compromising glucose-lowering activity","volume":"13","author":"Markowicz-Piasecka","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejphar.2025.177886_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103444","article-title":"Novel halogenated sulfonamide biguanides with anti-coagulation properties","volume":"94","author":"Markowicz-Piasecka","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejphar.2025.177886_bib24","series-title":"Incorporation of Sulfonamide Moiety into Biguanide Scaffold Results in Apoptosis Induction and Cell Cycle Arrest in MCF-7 Breast Cancer Cells","author":"Markowicz-Piasecka","year":"2021"},{"key":"10.1016\/j.ejphar.2025.177886_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109795","article-title":"Sulfonamide metformin derivatives induce mitochondrial-associated apoptosis and cell cycle arrest in breast cancer cells","volume":"352","author":"Markowicz-Piasecka","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2025.177886_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052687","article-title":"Alzheimer's disease as type 3 diabetes: common pathophysiological mechanisms between alzheimer's disease and type 2 diabetes","volume":"23","author":"Michailidis","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177886_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbapap.2008.10.016","article-title":"Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature","volume":"1794","author":"Morris","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2025.177886_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101979","article-title":"Antidiabetic agents as a novel treatment for alzheimer \u2019 s and Parkinson \u2019 s disease","volume":"89","author":"Nowell","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejphar.2025.177886_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbi.2017.12.009","article-title":"Metformin treatment prevents amyloid plaque deposition and memory impairment in APP\/PS1 mice","volume":"69","author":"Ou","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2025.177886_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1556\/ABiol.54.2003.2.7","article-title":"Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain","volume":"54","author":"Rakonczay","year":"2005","journal-title":"Acta Biol. Hung."},{"key":"10.1016\/j.ejphar.2025.177886_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ejphar.2025.177886_bib33","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Ronneberger","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177886_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/ph15040453","article-title":"Biological properties of transition metal complexes with metformin and its analogues","volume":"15","author":"Rusanov","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2025.177886_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejphar.2025.177886_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000453","article-title":"Hybridization-based design of novel anticholinesterase indanone\u2013carbamates for Alzheimer's disease: synthesis, biological evaluation, and docking studies","volume":"354","author":"Shahrivar-Gargari","year":"2021","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejphar.2025.177886_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024954","article-title":"Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus","volume":"9","author":"Shi","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejphar.2025.177886_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20420188231187493","article-title":"Exploring the mechanism of metformin action in Alzheimer's disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation","volume":"14","author":"Shi","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.ejphar.2025.177886_bib39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuint.2017.04.020","article-title":"Bidirectional interactions between diabetes and Alzheimer's disease","volume":"108","author":"Shinohara","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2025.177886_bib40","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1021\/acs.jcim.9b01073","article-title":"Donepezil inhibits acetylcholinesterase via multiple binding modes at room temperature","volume":"60","author":"Silva","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejphar.2025.177886_bib41","first-page":"1","article-title":"Alzheimer's disease pharmacotherapy in relation to cholinergic system involvement","volume":"10","author":"Stanciu","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2025.177886_bib42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.brainresbull.2021.02.018","article-title":"Cholinergic and metabolic effects of metformin in mouse brain","volume":"170","author":"Thinnes","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2025.177886_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2020.00170","article-title":"Metformin ameliorates synaptic defects in a mouse model of AD by inhibiting Cdk5 activity","volume":"14","author":"Wang","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177886_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-02370-3","article-title":"A\u03b242 pentamers\/hexamers are the smallest detectable oligomers in solution","volume":"7","author":"Wolff","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177886_bib45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0009-8981(99)00144-8","article-title":"Improved determination of acetylcholinesterase activity in human whole blood","volume":"288","author":"Worek","year":"1999","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2025.177886_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110381","article-title":"Substituent effects of sulfonamide derivatives of metformin that can dually improve cellular glucose utilization and anti-coagulation","volume":"373","author":"Zajda","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2025.177886_bib47","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925006405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925006405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:32:21Z","timestamp":1762144341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925006405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":46,"alternative-id":["S0014299925006405"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177886","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing the structure of repurposed metformin can improve anti-cholinesterase and anti-amyloidogenic effects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177886"}}